vs

Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and NAPCO SECURITY TECHNOLOGIES, INC (NSSC). Click either name above to swap in a different company.

NAPCO SECURITY TECHNOLOGIES, INC is the larger business by last-quarter revenue ($48.2M vs $44.9M, roughly 1.1× AbCellera Biologics Inc.). NAPCO SECURITY TECHNOLOGIES, INC runs the higher net margin — 28.0% vs -19.9%, a 48.0% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 12.2%). NAPCO SECURITY TECHNOLOGIES, INC produced more free cash flow last quarter ($14.5M vs $-44.6M). Over the past eight quarters, AbCellera Biologics Inc.'s revenue compounded faster (112.3% CAGR vs -1.1%).

AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.

Napco Security Technologies, Inc. was set up in 1969 and now is based in Amityville, New York. The company focuses on security products, such as electronic locking devices, alarm systems, and building access control systems. The company was formerly known as Napco Security Systems, Inc.

ABCL vs NSSC — Head-to-Head

Bigger by revenue
NSSC
NSSC
1.1× larger
NSSC
$48.2M
$44.9M
ABCL
Growing faster (revenue YoY)
ABCL
ABCL
+776.2% gap
ABCL
788.4%
12.2%
NSSC
Higher net margin
NSSC
NSSC
48.0% more per $
NSSC
28.0%
-19.9%
ABCL
More free cash flow
NSSC
NSSC
$59.1M more FCF
NSSC
$14.5M
$-44.6M
ABCL
Faster 2-yr revenue CAGR
ABCL
ABCL
Annualised
ABCL
112.3%
-1.1%
NSSC

Income Statement — Q4 FY2025 vs Q2 FY2026

Metric
ABCL
ABCL
NSSC
NSSC
Revenue
$44.9M
$48.2M
Net Profit
$-8.9M
$13.5M
Gross Margin
58.6%
Operating Margin
-63.7%
30.6%
Net Margin
-19.9%
28.0%
Revenue YoY
788.4%
12.2%
Net Profit YoY
73.9%
29.0%
EPS (diluted)
$-0.03
$0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ABCL
ABCL
NSSC
NSSC
Q4 25
$44.9M
$48.2M
Q3 25
$9.0M
$49.2M
Q2 25
$17.1M
$50.7M
Q1 25
$4.2M
$44.0M
Q4 24
$5.0M
$42.9M
Q3 24
$6.5M
$44.0M
Q2 24
$7.3M
$50.3M
Q1 24
$10.0M
$49.3M
Net Profit
ABCL
ABCL
NSSC
NSSC
Q4 25
$-8.9M
$13.5M
Q3 25
$-57.1M
$12.2M
Q2 25
$-34.7M
$11.6M
Q1 25
$-45.6M
$10.1M
Q4 24
$10.5M
Q3 24
$-51.1M
$11.2M
Q2 24
$-36.9M
$13.5M
Q1 24
$-40.6M
$13.2M
Gross Margin
ABCL
ABCL
NSSC
NSSC
Q4 25
58.6%
Q3 25
56.6%
Q2 25
52.8%
Q1 25
57.2%
Q4 24
57.0%
Q3 24
55.9%
Q2 24
55.3%
Q1 24
53.8%
Operating Margin
ABCL
ABCL
NSSC
NSSC
Q4 25
-63.7%
30.6%
Q3 25
-851.8%
27.7%
Q2 25
-290.2%
23.8%
Q1 25
-1479.6%
25.4%
Q4 24
26.0%
Q3 24
-1439.4%
26.9%
Q2 24
-1276.2%
27.7%
Q1 24
-551.5%
29.4%
Net Margin
ABCL
ABCL
NSSC
NSSC
Q4 25
-19.9%
28.0%
Q3 25
-637.8%
24.7%
Q2 25
-203.3%
22.9%
Q1 25
-1077.2%
23.0%
Q4 24
24.4%
Q3 24
-785.4%
25.4%
Q2 24
-504.3%
26.9%
Q1 24
-408.0%
26.8%
EPS (diluted)
ABCL
ABCL
NSSC
NSSC
Q4 25
$-0.03
$0.38
Q3 25
$-0.19
$0.34
Q2 25
$-0.12
$0.33
Q1 25
$-0.15
$0.28
Q4 24
$0.28
Q3 24
$-0.17
$0.30
Q2 24
$-0.13
$0.36
Q1 24
$-0.14
$0.36

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ABCL
ABCL
NSSC
NSSC
Cash + ST InvestmentsLiquidity on hand
$128.5M
$115.4M
Total DebtLower is stronger
Stockholders' EquityBook value
$966.9M
$184.8M
Total Assets
$1.4B
$212.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ABCL
ABCL
NSSC
NSSC
Q4 25
$128.5M
$115.4M
Q3 25
$83.2M
$105.8M
Q2 25
$92.4M
$99.2M
Q1 25
$159.3M
$89.3M
Q4 24
$156.3M
$99.2M
Q3 24
$126.6M
$91.3M
Q2 24
$148.3M
$70.7M
Q1 24
$123.6M
$60.9M
Stockholders' Equity
ABCL
ABCL
NSSC
NSSC
Q4 25
$966.9M
$184.8M
Q3 25
$964.0M
$176.1M
Q2 25
$1.0B
$168.6M
Q1 25
$1.0B
$161.5M
Q4 24
$1.1B
$174.2M
Q3 24
$1.1B
$178.6M
Q2 24
$1.1B
$178.9M
Q1 24
$1.1B
$168.2M
Total Assets
ABCL
ABCL
NSSC
NSSC
Q4 25
$1.4B
$212.8M
Q3 25
$1.4B
$206.0M
Q2 25
$1.4B
$198.1M
Q1 25
$1.3B
$190.9M
Q4 24
$1.4B
$202.7M
Q3 24
$1.4B
$209.9M
Q2 24
$1.4B
$207.8M
Q1 24
$1.5B
$194.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ABCL
ABCL
NSSC
NSSC
Operating Cash FlowLast quarter
$-34.7M
$15.1M
Free Cash FlowOCF − Capex
$-44.6M
$14.5M
FCF MarginFCF / Revenue
-99.4%
30.1%
Capex IntensityCapex / Revenue
21.9%
1.2%
Cash ConversionOCF / Net Profit
1.12×
TTM Free Cash FlowTrailing 4 quarters
$-174.1M
$53.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ABCL
ABCL
NSSC
NSSC
Q4 25
$-34.7M
$15.1M
Q3 25
$-52.6M
$11.6M
Q2 25
$-32.4M
$14.6M
Q1 25
$-11.6M
$13.4M
Q4 24
$-108.6M
$13.5M
Q3 24
$-28.9M
$12.0M
Q2 24
$-30.0M
$14.3M
Q1 24
$-41.7M
$12.3M
Free Cash Flow
ABCL
ABCL
NSSC
NSSC
Q4 25
$-44.6M
$14.5M
Q3 25
$-61.5M
$11.4M
Q2 25
$-45.8M
$14.4M
Q1 25
$-22.2M
$13.3M
Q4 24
$-187.0M
$12.4M
Q3 24
$-47.4M
$11.3M
Q2 24
$-50.1M
$13.8M
Q1 24
$-65.8M
$12.0M
FCF Margin
ABCL
ABCL
NSSC
NSSC
Q4 25
-99.4%
30.1%
Q3 25
-687.0%
23.3%
Q2 25
-267.9%
28.4%
Q1 25
-524.0%
30.3%
Q4 24
-3702.8%
28.8%
Q3 24
-728.4%
25.8%
Q2 24
-683.8%
27.4%
Q1 24
-661.5%
24.3%
Capex Intensity
ABCL
ABCL
NSSC
NSSC
Q4 25
21.9%
1.2%
Q3 25
99.7%
0.4%
Q2 25
78.2%
0.5%
Q1 25
251.1%
0.1%
Q4 24
1552.7%
2.6%
Q3 24
284.6%
1.5%
Q2 24
274.6%
1.1%
Q1 24
242.5%
0.7%
Cash Conversion
ABCL
ABCL
NSSC
NSSC
Q4 25
1.12×
Q3 25
0.96×
Q2 25
1.26×
Q1 25
1.32×
Q4 24
1.29×
Q3 24
1.08×
Q2 24
1.06×
Q1 24
0.94×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons